Clinical Trial Update: Biomarkers in Samples From Patients With Down Syndrome and Acute Megakaryoblastic Leukemia

View source ↗

Summary

Clinical trial update summarizing biomarker analyses from samples of patients with Down syndrome-associated acute megakaryoblastic leukemia in a completed study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Down Syndrome
• Megakaryoblastic Leukemia

Snippet

Sponsor: Children's Oncology Group | Conditions: Leukemia | Status: COMPLETED